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Abstract. A biofilm is an accumulation of micro-organisms and their extracellular products forming a structured community
on a surface. Biofilm formation on medical devices has severe health consequences as bacteria growing in this lifestyle are
tolerant to both host defence mechanisms and antibiotic therapies. However, silver and zinc ions inhibit the attachment and
proliferation of immature biofilms. The objective of this study is to evaluate whether silver and zinc ions eluted from novel
glass polyalkenoate cement (GPC) coatings have the ability to inhibit Methicillin-resistant Staphylococcus aureus (MRSA)
in vivo. A silver and zinc-containing GPC coating was synthesised, deposited onto Ti6Al4V discs and placed in a specified
amount of analytical water for 1, 7 and 30 days. The resulting elutes were collected and Atomic absorption spectroscopy was
used to measure ion release. The elutes were injected into Galleria mellonella larvae infected with MRSA and the antibacterial
properties of these elutes were evaluated in vivo. The majority of the zinc and silver ions were released within the first 24 h;
this corresponded with the greatest degree of protection observed in infected larvae. Results were compared to a conventional
in vitro model where identical elutes were incubated with MRSA on nutrient agar. These results were consistent with those
observed in the larval model, demonstrating a reduction in bacterial viability when co-cultured with elutes for 2 h. This work
confirms the promise of the Galleria mellonella as a model for the assessment of antimicrobial agents and demonstrates the
capacity of novel silver and zinc-containing GPCs to retard the colonisation of MRSA.
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1. Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is the most commonly identified antibiotic-
resistant pathogen in the developed world [1,2]. Although S. aureus was discovered in the 1950s, con-
cerns were not raised until the 1980s with the identification of antibiotic resistant strains. With MRSA,
mortality can be double that of a corresponding infection with an antibiotic-susceptible strain and mor-
bidity far more extensive [1,2]. S. aureus persistently colonises at least one-third of mankind [3]. Once
the human body’s physical and immunological defences are compromised, S. aureus can cause infection.
There are approximately 10,000 cases per year in the UK of blood stream infections (bacteraemia) with
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MRSA with a mortality rate of 40–50% and the incidence of S. aureus bacteraemia is 32 per 100,000
inhabitants in Ireland [2].
We have previously shown that silver and zinc-containing glass polyalkenoate cements (GPCs) elimi-
nated S. aureus bacteria in vitro [4]. GPCs, formed by the reaction between an ion-leachable glass and an
aqueous solution of polyacrylic acid (PAA) [5], have proven to be both antibacterial and cariostatic [5];
properties related to their ability to release beneficial amounts of therapeutic ions [6,7]. Commercially
available GPCs are all based on aluminium glass chemistry [8]. However, the presence of aluminium
retards the medical and surgical applications of such cements as aluminium ion (Al3+) released in vivo
can cause demineralisation of the bone [9] and has been implicated in the pathogenesis of degenerative
brain diseases including Parkinson’s and Alzheimer’s disease [10,11]. The zinc ion (Zn2+) performs
a similar role in glass forming, to the Al3+ ion, in that it has the ability to act as an intermediate oxide,
but it does not cause defective bone mineralisation [11,12].
Zn2+ is known to be antibacterial. Studies have shown that inhibition of bacterial growth correlates
with released zinc from zinc phosphate cements (ZPC) [13] and zinc sulphate incorporated GPCs [14,
15]. The minimum zinc concentration required for bacterial inhibition of MRSA is 3× 10−2 ppm [16].
Zinc inhibits multiple activities in the bacterial cell including glycolysis, transmembrane proton translo-
cation and acid tolerance [17]. Silver is also a known antibacterial agent [18,19] as the silver ion (Ag+)
binds to negatively charged components in proteins and nucleic acids, thereby causing structural changes
in bacterial cell walls, membranes and nucleic acids that affect bacterial cell viability [20]. To have an-
timicrobial efficacy against MRSA, silver ions must be released in biocidal concentrations of at least
7.94 ppm [21].
The objective of this research is to determine the antibacterial efficacy of novel silver and zinc-
containing GPCs against MRSA in a novel in vivo based study. The larvae of Galleria mellonella
(G. mellonella) have been used as non-mammalian hosts to study the virulence of bacterial and fun-
gal pathogens [22–25]. Similar to mammals, insects possess a circulatory system and comparable innate
immune responses [26]. Analysis of insect responses to pathogens can provide an accurate indication
of the innate mammalian response to that pathogen and a useful non-mammalian model for drug eval-
uation [23,27]. G. mellonella is an excellent model to work with as the species are of suitable weight
(250–400 mg) to allow for rapid delivery of pathogenic bacteria and thus examination of the inflamma-
tory response to infection. There is also substantial correlation between the virulence of certain microbes
in mice and in the G. mellonella model [26,28]. Although the use of higher animals such as mice and rats
in most in vivo studies provide excellent results, the use of G. mellonella provides a screening method
that is more cost-effective, less labour-intensive and more ethically acceptable.
2. Materials and methods
2.1. Glass synthesis and characterisation
One glass (56.04SiO2, 32.76ZnO, 0.33Ag2O and 10.87Na2O, mol. fraction), was synthesised by the
melt quench route. Full details of the synthesis procedure have previously been reported by the au-
thors [5] but are repeated for completeness. Appropriate amounts of analytical grade reagents were
weighed out in a plastic tub and mixed in a ball mill (1 h), then dried in a vacuum oven (100◦C, 1 h).
The reagents were fired in mullite crucibles (1480◦C, 1 h) and shock quenched into water. The resulting
frit underwent grinding in a gyromill and the glass powder was passed through a 25 µm sieve. All further
work was undertaken on the sub 25 µm particles.
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The GPC was prepared by mixing 0.5 g glass, with 0.2 g polyacrylic acid (PAA) and 0.25 ml distilled
water. Ciba specialty polymers (Bradford, UK) supplied the PAA (Mw, 210,000) in aqueous solution
(25 vol%). The PAA was subsequently freeze dried and ground (maximum particle size, 90 µm). Mixing
was undertaken on a glass plate with a dental spatula in ambient laboratory conditions. The working
time (the duration from commencement of mixing to the point when the cement is no longer pliable)
and setting time [29] of the GPC was determined.
2.2. Coating preparation
Coatings were produced by spreading cement onto Ti6Al4V discs (Engineering Sheets Limited, Lim-
erick, Ireland) of known size (25 mm Ø, 2 mm). Each construct was then clamped to another Ti6Al4V
disc, separated from the coating by an acetate sheet. This sandwich structure was then stored in an oven
(37oC, 24 h), prior to declamping.
2.3. Ion release
Evaluation of both Zn2+ and Ag+ ion release was undertaken at 1, 7 and 30 days by Atomic Absorp-
tion Spectroscopy (AAS). The constructs were matured in analytical water (Reagecon Limited, Shannon,
Ireland); with up to 65 ml of water immersing the samples. The amount of water was calculated using
Eq. (1).
Rate of Solution = SA
10 + x; (1)
SA – surface area; x – a constant fixed number.
Full methodology has been reported previously [5], but will be repeated for completeness. Standard
solutions of silver and zinc were formulated as per the literature [30]; zinc concentrations of 0.1, 0.5, 1.0
and 2.0 ppm and silver concentrations of 0.5, 1.0, 5.0 and 10.0 ppm.
Ion release was evaluated using the Varian Spectra AA-220 FS Atomic Absorption Spectrometer
(AAS, Varian, Australia) from each construct immersed in water (n = 3). Five 1 ml extracts were taken
from each sample. The zinc concentrations released from the coatings exceeded the detection limit of
the apparatus and, for this reason, the solutions for evaluation of zinc release were diluted (1:10) with
purified water. The pH of the solutions was also evaluated using an Accumet Portable pH/mV/◦C Meter
(Fisher Scientific, Ireland). Calibration was with pH4 and pH6 buffers.
2.4. Preparation of the inoculum
A 0.1 M solution of potassium phosphate buffer (PPB) was made by preparing, separately, a 1 M
solution of dipotassium phosphate (K2HPO4) and a 1 M solution of potassium dihydrogen phosphate
(KH2PO4), then adding 71.7 ml of K2HPO4 to 28.3 ml KH2PO4 to make 1 M potassium phosphate
buffer at pH 7.2 and bringing the total volume to 1 l (thereby diluting 1:10) with distilled water to make
a 0.1 M final solution.
Two dilutions of the elutes were undertaken. These were:
– 5% elute test.
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50 µl of elute was added to replicate bacterial cultures in a final volume of 1 ml PPB. The culture had
been grown to log phase and adjusted to a final conc. of 5× 105 cfu/ml.
– 10% elute test.
100 µl of elute was added to replicate bacterial cultures in a final volume of 1 ml PPB. The culture
had been grown to log phase and adjusted to a final conc. of 5× 105 cfu/ml.
Identical elute dilutions and bacterial concentrations were used in the subsequent in vitro antibacterial
testing.
2.5. Antibacterial testing
Two antibacterial tests were performed; one in vitro and one in vivo.
2.5.1. In vitro
MRSA was incubated with or without the 5% and 10% elutes in an orbital incubator for 2 h (37◦C,
200 rpm). The concentration of viable bacteria was determined by colony counting; 100 µl of serially
diluted cultures were spread onto nutrient agar in triplicate and incubated at 37◦C overnight. The num-
ber of bacterial colonies were counted using Quantity One Quantitation Software v4.4.1 (BioRad, CA,
USA). Viability was determined as the percentage of a colony count compared to cultures of non-elute
treated bacteria. Significance was determined by a paired t-test analysis.
2.5.2. In vivo
A non-mammalian model previously used to assess antibiotic efficacy was adapted for use in this
study [28]. G. mellonella in final larval stage were stored in the dark before being infected with 1× 106
CFU/larvae of MRSA. Delivery was by microinjection into the last proleg. After 20 m recovery, a second
injection of either 20 µl 1 mM PPB or 20 µl scaffold elute was administered. The larvae were then held
in a 30oC incubator and assessed for viability at 48 and 72 h. Six G. mellonella were used per treatment.
G. mellonella that received no bacteria remained 100% viable. Larvae were assessed for responsiveness
(movement) and colour (yellow or black), where discolouration is indicative of innate immune activation
and melanisation (Fig. 1).
Fig. 1. G. Mellonella: Dead larvae are black and living larvae are yellow.
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3. Results and discussion
3.1. Glass synthesis and characterisation
The glass was produced and characterised as outlined in the methods section.
3.2. Cement characterisation
The cement was formulated by mixing the glass powders with the PAA and water at the ratio stated in
Section 2.2. Working and setting times are shown in Table 1.
The cements have long setting times which helps to ensure high levels of ion release.
3.3. Ion release evaluation
The cumulative levels of Zn2+ and Ag+ released were evaluated using AAS. This data has already
been documented [5] but is repeated in Fig. 2, for completeness. A pH of 7 was recorded for all solutions
at all time frames. It is evident that the majority of both Zn2+ (1.5 ppm) and Ag+ (0.2 ppm) release occurs
in the first 24 h, but there is a continual release (Fig. 2) throughout the evaluation period (30 days), with
another 1 ppm Zn2+ being released after 7 days and the remaining 1 ppm being released over 30 days.
Over the next 29 days, only an additional 0.1 ppm Ag+ was released by the coatings.
3.4. Antibacterial evaluation
3.4.1. In vitro test
The results of the colony counts are displayed schematically in Fig. 3.
Table 1
Working and setting times of the cement formulation
Cement Wt St
A 5 m 22 s 16 h 15 m 23 s
Fig. 2. Cumulative ion release profiles for zinc and silver from the GPC.
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Fig. 3. 1, 7 and 30 day and Control (water) of the 5% and 10% colonies Each point represents the mean ± SE of triplicate
results, significance was determined by paired t-test compared with water control, ***p < 0.005, **p < 0.05.
Fig. 4. 1, 7 and 30 day and control images of the 5% colony count.
Fig. 5. 1, 7 and 30 day and control images of the 10% colony count.
A significant reduction in bacterial viability was observed for both the 5% and 10% dilutions of day 1,
7 and 30 elutes when compared with controls (Figs 4 and 5). Day 30 elutes showed a reduced but effi-
cacious antibacterial function. As expected, these results corresponded with the levels of Zn2+ and Ag+
measured in the GPC solutions, demonstrating greater microbicidal function at higher concentrations.
These results indicate that the levels of Zn2+ and Ag+ released from the GPC are at concentrations
high enough to reduce the viability of MRSA and that while the levels of each reduces over time, the
elutes remain effective up to 30 days. With reference to the literature, Zn2+ release from these coat-
ings was measured in biocidal concentrations for MRSA (>3× 10−2 ppm) [17], but below toxic levels
for humans [31]. However, the concentration of Ag+ released were both below biocidal concentrations
for MRSA (7.94 ppm) [21] and toxic levels for humans [21]. This antibacterial efficacy is independent
of pH, given that a pH of 7 was recorded for all solutions at all time frames, inferring that the metal ion
release, and not H+ release from the polyacrylic acid, is responsible for the coatings’ antibacterial effi-
cacy. From this, it can be assumed that the Zn2+ release, not the Ag+ or pH effects, cause antibacterial
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Fig. 6. 1, 7 and 30 day elutes % survival at 48 and 72 h. Each point represents the mean ± SE.
efficacy. However, further tests need to be performed on comparable coatings with no silver content to
confirm this finding.
3.4.2. In vivo test
The viability of G. mellonella larvae were assessed at 48 and 72 h, post treatment (Fig. 6). Larvae
were infected with S. aureus MRSA followed by cement elutes from 1, 7 and 30 days, or control 1 mM
PPB. Larvae that were not infected remained 100% viable both in terms of movement and colouration.
G. Mellonella that received the control 1 mM PPB post infection were all non-viable (immobile and
discoloured) at 48 h. Viability was rescued with the addition of GPC elutes from 1 and 7 days up to 72 h
post infection. Larval survival was maintained with day 1 elutes but demonstrated reduced efficacy over
time in the G. Mellonella that received 7 day elutes. GPC elutes from 30 day demonstrated no beneficial
effects when administered, resulting in 100% mortality at 48 h. Confirming the results observed in vitro,
antimicrobial function by GPC elutes in an in vivo larval model correlated with the concentration of
zinc and silver ions. Elutes that contained the highest ion levels exhibited the greatest capacity to inhibit
bacterial colonisation.
4. Conclusion
Biofilm formation on medical devices has severe health consequences as it provides a sanctuary for
bacteria which are tolerant to both host defence mechanisms and antibiotic therapies. However, Zn2+
and Ag+ are known to inhibit the attachment and proliferation of immature biofilms. The objective of
this work was to determine, using a novel in vivo test modality and an accepted in vitro test modality as
control, the ability of zinc and silver ion release, from novel GPCs, to inhibit or retard the colonisation
of MRSA. It is evident that the majority of both Zn2+ and Ag+ release occurs in the first 24 h, but there
is a continual release (Fig. 2) throughout the evaluation period (30 days). A serendipitous effect of this
work is that G. mellonella may be suitable as a pre screening tool to determine the antibacterial efficacy
of solutions, minimising the need for small animal testing in the future.
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